Apimeds Pharmaceuticals amends bylaws to allow shareholder action by written consent

Apimeds Pharmaceuticals US, Inc.

Board adopted First Amendment to Bylaws on October 15, 2025, effective immediately.
Amendment permits shareholders to take action by written consent without a meeting.
Change provides shareholders an additional mechanism to act outside of annual or special meetings.
No other changes to the bylaws were made; full amendment filed as Exhibit 3.1.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.